The decline in breast cancer mortality in Europe: An update (to 2009)

Breast

Volumn 21, Issue 1, 2012, Pages 77-82

  Bosetti, Cristina ^a   Bertuccio, Paola ^a   Levi, Fabio ^b   Chatenoud, Liliane ^a   Negri, Eva ^a   La Vecchia, Carlo ^a,c,d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF MILAN   (Italy)

^d INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Breast; Cancer; Europe; Mortality; Trends

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUSTRIA; BELARUS; BELGIUM; BREAST CANCER; BULGARIA; CANCER INCIDENCE; CANCER MORTALITY; CROATIA; CZECH REPUBLIC; DENMARK; ESTONIA; EUROPE; EUROPEAN UNION; FINLAND; FRANCE; GERMANY; GREECE; HUMAN; HUNGARY; IRELAND; ITALY; LATVIA; LITHUANIA; LUXEMBOURG; MAJOR CLINICAL STUDY; MALTA; NETHERLANDS; NORWAY; POLAND; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROMANIA; RUSSIAN FEDERATION; SLOVAKIA; SLOVENIA; SPAIN; SWEDEN; SWITZERLAND; UKRAINE; UNITED KINGDOM;

EID: 84856355544     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.08.001     Document Type: Article

References (44)

1. Levi F., Bosetti C., Lucchini F., Negri E., La Vecchia C. Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 2005, 14:497-502.
2. La Vecchia C., Bosetti C., Lucchini F., Bertuccio P., Negri E., Boyle P., et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2010, 21:1323-1360.
3. Autier P., Boniol M., La Vecchia C., Vatten L., Gavin A., Hery C., et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010, 341:c3620.
4. World Health Organization Statistical Information System. WHO mortality database Available at: (Last accessed April 2011). http://www3whoint/whosis/menucfm/.
5. International Classification of Disease: 8th revision 1967, World Health Organization, World Health Organization, Geneva.
6. International Classification of Disease: 9th revision 1977, World Health Organization, World Health Organization, Geneva.
7. International Classification of Disease and related Health Problems: 10th revision 1992, World Health Organization, World Health Organization, Geneva.
8. Doll R., Smith P.G. Comparison between registries: age-standardized rates. Cancer incidence in Five Continents 1982, vol. IV:671-675. IARC Sci Publ No. 42, IARC, Lyon. J.A.H. Waterhouse, C.S. Muir, K. Shanmugaratnam, J. Powell, D. Peacham, S. Whelan (Eds.).
9. Joinpoint Regression Program, version 3.5 April 2011, National Cancer Institute, Available at. http://srabcancergov/joinpoint/.
10. Kim H.J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. (Erratum in: Stat Med 2001;20: 655). Stat Med 2000, 19:335-351.
11. Peto R., Boreham J., Clarke M., Davies C., Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000, 355:1822.
12. Kohler B.A., Ward E., McCarthy B.J., Schymura M.J., Ries L.A., Eheman C., et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. JNatl Cancer Inst 2011, 103:714-736.
13. Levi F., Lucchini F., Negri E., La Vecchia C. The fall in breast cancer mortality in Europe. Eur J Cancer 2001, 37:1409-1412.
14. Jatoi I., Miller A.B. Why is breast-cancer mortality declining?. Lancet Oncol 2003, 4:251-254.
15. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
16. Dowsett M., Cuzick J., Ingle J., Coates A., Forbes J., Bliss J., et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. JClin Oncol 2010, 28:509-518.
17. Correa C., McGale P., Taylor C., Wang Y., Clarke M., Davies C., et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. JNatl Cancer Inst Monogr 2010, 2010:162-177.
18. Cuzick J., Decensi A., Arun B., Brown P.H., Castiglione M., Dunn B., et al. Preventive therapy for breast cancer: a consensus statement. Lancet Oncol 2011, 12:496-503.
19. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44:1345-1389.
20. Tyczynski J.E., Plesko I., Aareleid T., Primic-Zakelj M., Dalmas M., Kurtinaitis J., et al. Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer 2004, 112:1056-1064.
21. Autier P., Boniol M., Middleton R., Dore J.F., Hery C., Zheng T., et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 2011, 22:1726-1735.
22. Kalager M., Zelen M., Langmark F., Adami H.O. Effect of screening mammography on breast-cancer mortality in Norway. NEngl J Med 2010, 363:1203-1210.
23. IARC Handbook of Cancer Prevention. Breast cancer screening 2002, vol. 7. IARC, International Agency for Research on Cancer, Lyon, France.
24. Botha J.L., Bray F., Sankila R., Parkin D.M. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003, 39:1718-1729.
25. Colditz G.A., Baer H.J., Tamimi R.M. Breast cancer. Cancer Epidemiology and Prevention 2006, 995-1012. Oxford University Press, New York. 3th ed. D. Schottenfeld, J.F. Fraumeni (Eds.).
26. Rossouw J.E., Anderson G.L., Prentice R.L., Lacroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
27. Ravdin P.M., Cronin K.A., Howlader N., Berg C.D., Chlebowski R.T., Fever E.J., et al. The decrease in breast-cancer incidence in 2003 in the United States. NEngl J Med 2007, 356:1670-1674.
28. Jemal A., Ward E., Thun M.J. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007, 9:R28.
29. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet 2008, 372:608-610.
30. Pelucchi C., Levi F., La Vecchia C. The rise and fall in menopausal hormone therapy and breast cancer incidence. Breast 2010, 19:198-201.
31. La Vecchia C., Negri E., Franceschi S., Talamini R., Bruzzi P., Palli D., et al. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer 1997, 75:441-444.
32. Mezzetti M., La Vecchia C., Decarli A., Boyle P., Talamini R., Franceschi S. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. JNatl Cancer Inst 1998, 90:389-394.
33. Weight control and physical activity. IARC Handbooks on cancer prevention 2002, vol. 6. IARC, International Agency for Research on Cancer, Lyon, France.
34. Silventoinen K., Sans S., Tolonen H., Monterde D., Kuulasmaa K., Kesteloot H., et al. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord 2004, 28:710-718.
35. Gallus S., Colombo P., Scarpino V., Zuccaro P., Negri E., Apolone E., et al. Overweight and obesity in Italian adults 2004, and an overview of trends since 1983. Eur J Clin Nutr 2006, 60:1174-1179.
36. Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Bouvard V., et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007, 8:292-293.
37. Pollan M., Pastor-Barriuso R., Ardanaz E., Arguelles M., Matros C., Galceran J., et al. Recent changes in breast cancer incidence in Spain, 1980-2004. JNatl Cancer Inst 2009, 101:1584-1591.
38. Percy C., Stanek E., Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981, 71:242-250.
39. Muir C.S., Percy C. Classification and coding for neoplasms. Cancer registration: principles and methods 1991, 64-81. IARC. O.M. Jensen, D.M. Parkin, R. MacLennan, C.S. Muir, R.G. Skeet (Eds.).
40. Rooney C., Devis T. Mortality trends by cause of death in England and Wales 1980-94: the impact of introducing automated cause coding and related changes in 1993. Popul Trends 1996, 29-35.
41. Shkolnikov V.M., McKee M., Vallin J., Aksel E., Leon D., Chenet L., et al. Cancer mortality in Russia and Ukraine: validity, competing risks and cohort effects. Int J Epidemiol 1999, 28:19-29.
42. Doll R. Progress against cancer: an epidemiologic assessment. The 1991 John C. Cassel Memorial Lecture. Am J Epidemiol 1991, 134:675-688.
43. Muir C.S., Fraumeni J.F., Doll R. The interpretation of time trends. Cancer Surv 1994, 19-20:5-21.
44. Malvezzi M., Arfe A., Bertuccio P., Levi F., La Vecchia C., Negri E. European cancer mortality predictions for the year 2011. Ann Oncol 2011, 22:947-956.